Lift Biosciences -

LIfT BioSciences is a UK-based biotechnology company developing first-in-class, off-the-shelf neutrophil-lineage cell therapies called Immunomodulatory Alpha Neutrophils (IMANs). These therapies are designed to directly kill tumor cells and re-ignite anti-tumor immunity in cancer patients with solid tumors. LIfT BioSciences is preparing for its first-in-human clinical study to assess IMANs' safety and efficacy in patients with advanced cervical and head & neck cancers.